Oral treatment with Narciclasine at 1 mg/kg significantly increases the survival (P=0
InChi: InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8
BSc3094 (0
is a discontinued (DEA controlled substance) biochemical
PF-945863 4413 Oral treatment with Narciclasine atPF 945863 is an orally active macrolide antibiotic that can be used for the research of multidrug resistant respiratory tract bacterial strains. Product information CAS Number: 893556 85 9 Molecular Weight: 824. 01 Formula: C44H65N5O10 Chemical Name: (3aS,4R,7R,9R,10R,11R,13R,15R,15aR) 10 {[(2S,3R,4S,6R) 4 (dimethylamino) 3 hydroxy 6 methyloxan 2 yl]oxy} 4 ethyl 11 methoxy 3a,7,9,11,13,15 hexamethyl 1 {1 [(1R) 1 (1,8 naphthyridin 4 yl)ethyl]azetidin 3